infect
cell
anim
virus
membran
permeabl
modifi
two
differ
step
viru
life
cycl
carrasco
figur
initi
virion
enter
cell
number
differents
molecul
abl
coenter
cytoplasm
viru
particl
fernandezpuent
otero
carrasco
membran
potenti
revers
destroy
restor
sever
minut
later
endosom
involv
coentri
process
sinc
inhibitor
proton
atpas
block
earli
permeabil
even
virus
requir
endosom
function
chemiosmot
model
advanc
explain
molecular
basi
earli
membran
modif
viru
particl
carrasco
viral
molecul
involv
compon
virion
glycoprotein
envelop
particl
analyz
still
unidentifi
domain
structur
protein
case
nake
virus
attach
particl
cell
surfac
receptor
alter
membran
permeabl
inhibitor
hamper
viru
decapsid
still
allow
viru
attach
cell
surfac
block
earli
membran
permeabil
almela
et
al
late
time
infect
activ
translat
late
viral
mrna
plasma
membran
becom
permeabl
small
molecul
ion
carrasco
figur
differ
viral
molecul
may
respons
late
enhanc
membran
permeabl
includ
viroporin
gonzalez
carrasco
glycoprotein
even
proteas
chang
et
al
blanco
et
al
chapter
devot
review
characterist
membran
permeabil
viral
protein
addit
methodolog
use
assay
enhanc
permeabl
anim
cell
describ
final
design
select
viral
inhibitor
base
modif
cellular
membran
viru
entri
late
time
infect
also
discuss
number
hydrophil
molecul
includ
antibiot
poorli
permeat
cellular
membran
contrera
et
al
lacal
et
al
case
hygromycin
b
anthelmycin
blasticidin
destomycin
gougerotin
edein
complex
aminoglycosid
antibiot
hygromycin
b
mw
produc
streptomyc
hygroscopicu
hydrophil
molecul
effici
inhibitor
protein
synthesi
cellfre
system
interfer
poorli
translat
intact
cell
howev
modif
plasma
membran
virus
mean
lead
rapid
blockad
translat
carrasco
concentr
antibiot
rang
mm
ad
cultur
medium
protein
synthesi
estim
incub
radioact
methionin
hr
see
figur
gonzalez
carrasco
addit
simplic
hygromycin
b
test
number
advantag
assay
chang
membran
permeabl
one
great
sensit
anoth
test
measur
membran
modif
cell
metabol
activ
moreov
cultur
cell
uninfect
hygromycin
b
would
enter
virusinfect
cell
synthes
protein
hygromycin
b
test
appli
success
prokaryot
lama
carrasco
eukaryot
cell
includ
yeast
carrasco
mammalian
cell
gatti
et
al
gonzalez
carrasco
alphasarcin
unabl
pass
pore
alphasarcin
protein
amino
acid
residu
produc
aspergillu
giganteu
oka
et
al
protein
inhibit
translat
modifi
ribosom
enzymat
manner
thu
molecul
alphasarcin
abl
inactiv
great
number
ribosom
hydrolysi
phosphodiest
bond
rrna
chan
et
al
toxin
enter
mammalian
cell
attach
cell
surfac
therefor
unabl
cross
plasma
membran
howev
alphasarcin
effici
interfer
protein
synthesi
cellfre
system
cell
permeabl
barrier
destroy
fernandezpuent
alphasarcin
coenter
cell
conjunct
viru
particl
liber
cytoplasm
otero
carrasco
liprandi
et
al
manner
toxin
irrevers
block
translat
sever
minut
viru
entri
molecular
basi
coentri
macromolecul
viru
particl
analyz
detail
elsewher
carrasco
carrasco
apart
alphasarcin
number
protein
interfer
translat
mani
plant
origin
describ
fernandezpuent
carrasco
lee
et
al
releas
toxin
cell
enhanc
viru
particl
protein
also
macromolecul
includ
nucleic
acid
effici
coenter
viru
particl
cotten
et
al
howev
none
macromolecul
pass
cell
late
time
infect
apart
use
translat
inhibitor
easili
permeat
intact
cell
number
assay
employ
assess
modif
membran
permeabl
amongst
assay
list
follow
cell
preload
radioact
uridin
exit
nucleotid
monitor
induct
viroporin
express
gonzalez
carrasco
unlik
amino
acid
pool
uridin
nucleotid
abund
cell
interior
thu
provid
conveni
sensit
assay
monitor
exit
molecul
cell
test
use
radioact
glucos
deriv
eg
metabol
accumul
cell
analysi
releas
radioact
compound
activ
transport
cell
lead
failur
measur
enhanc
membran
permeabl
entri
onpg
bacteri
cell
determin
simpli
substrat
incub
bacteri
cell
product
result
compound
follow
determin
absorb
nm
lama
carrasco
number
nonvit
dye
employ
character
cell
mortal
note
entri
compound
fact
determin
modif
cell
membran
case
directli
correl
cell
death
trypan
blue
dye
wide
use
monitor
enhanc
membran
permeabl
howev
assay
sensit
addit
trypan
blue
stain
discrimin
metabol
activ
dead
cell
hygromycin
b
test
anoth
assay
employ
polyamin
neurobiotin
need
specif
connexin
channel
enter
mammalian
cell
elfgang
et
al
permeabil
cell
membran
increas
uptak
cation
molecul
intern
neurobiotin
detect
paraformaldehydefix
cell
fluoresc
microscopi
use
fluorescein
isothiocyanateconjug
streptavidin
gonzalez
carrasco
propidium
iodid
pi
dnaintercal
compound
enter
intact
cell
howev
cell
exhibit
increas
membran
permeabl
abl
take
pi
assay
cell
fluorometr
analysi
arroyo
et
al
appear
cultur
medium
cellular
enzym
clear
indic
cell
mortal
case
lactic
dehydrogenas
bacteri
present
outsid
cell
sanderson
et
al
commerci
kit
measur
enzymat
activ
avail
releas
cellular
protein
medium
occur
late
time
viral
infect
cell
alreadi
die
alter
take
place
much
later
time
hygromycin
b
entri
detect
blanco
et
al
viroporin
small
protein
encod
virus
contain
stretch
hydrophob
amino
acid
gonzalez
carrasco
typic
viroporin
compris
amino
acid
hydrophob
domain
abl
form
amphipath
insert
protein
membran
follow
oligomer
creat
hydrophil
pore
architectur
channel
hydrophob
amino
acid
residu
face
phospholipid
bilay
hydrophil
residu
form
part
pore
addit
domain
featur
viroporin
structur
includ
second
hydrophob
region
viroporin
also
interact
membran
second
interact
may
disturb
organ
lipid
bilay
protein
may
also
contain
stretch
basic
amino
acid
act
detergentlik
fashion
structur
featur
contribut
membran
destabil
recent
anoth
domain
describ
glycoprotein
also
viroporin
capac
interact
membran
domain
rich
aromat
amino
acid
usual
insert
interfac
phospholipid
bilay
suarez
et
al
sanz
et
al
type
interact
also
lead
membran
destabil
enhanc
membran
permeabl
number
viroporin
differ
virus
infect
eukaryot
cell
report
group
protein
includ
picornaviru
alphaviru
retroviru
vpu
paramyxoviru
sh
orthomyxoviru
reoviru
flaviviru
phycodnaviru
kcv
coronaviru
e
rhabdoviru
alpha
recent
review
devot
viroporin
discuss
structur
function
number
protein
group
gonzalez
carrasco
detail
particular
viroporin
review
chapter
main
activ
viroporin
creat
pore
biolog
membran
permit
passag
ion
small
molecul
clone
individu
express
viroporin
gene
allow
effect
bacteri
anim
cell
analyz
thu
express
type
viral
gene
enhanc
permeat
ion
sever
hydrophil
molecul
cell
carrasco
addit
purifi
viroporin
molecul
open
pore
model
membran
provid
system
amen
biophys
analysi
fischer
sansom
pore
size
creat
viroporin
allow
diffus
differ
molecul
molecular
weight
da
main
step
affect
anim
virus
contain
delet
viroporin
gene
assembl
exit
virion
infect
cell
klimkait
et
al
liljestrom
et
al
loewi
et
al
betakova
et
al
watanab
et
al
kuo
master
gene
essenti
viru
replic
cultur
cell
plaqu
size
much
smaller
viroporindefect
virus
notabl
viru
entri
gene
express
viroporindelet
virus
occur
wildtyp
counterpart
aspect
viroporin
function
molecular
level
still
understood
link
pore
activ
viru
bud
addit
small
hydrophob
viral
protein
viru
product
promot
membran
permeabil
occur
number
viru
glycoprotein
gp
known
increas
cell
membran
permeabl
human
immunodefici
viru
chernomordik
et
al
arroyo
et
al
ebola
viru
gp
yang
et
al
cytomegaloviru
protein
maidji
et
al
vaccinia
viru
protein
sanderson
et
al
rotaviru
protein
charpilienn
et
al
newton
et
al
hepat
c
viru
protein
ciccaglion
et
al
alphaviru
protein
nyfel
et
al
wengler
et
al
architectur
viral
glycoprotein
upon
oligomer
transmembran
tm
domain
may
form
physic
pore
principl
two
differ
region
viral
fusion
glycoprotein
could
form
pore
one
region
contain
fusion
peptid
would
creat
pore
cell
membran
upon
insert
skehel
wiley
tm
domain
would
form
pore
virion
membran
wild
et
al
moreov
sequenc
adjac
tm
region
could
motif
design
destabil
membran
structur
suarez
et
al
entri
envelop
anim
virus
lead
earli
membran
permeabil
mediat
format
two
pore
fusion
tm
form
viral
fusion
glycoprotein
earli
permeabil
induc
entri
virion
requir
conform
chang
fusion
glycoprotein
contrast
viru
replic
newli
synthes
glycoprotein
may
affect
membran
permeabl
reach
plasma
membran
figur
modif
achiev
tm
domain
fusion
peptid
particip
late
modif
virus
lack
typic
viroporin
function
could
replac
poreform
glycoprotein
virus
viroporin
activ
may
redund
bour
strebel
latter
case
pore
format
may
gener
viral
glycoprotein
viroporin
figur
would
like
propos
possibl
poreform
glycoprotein
play
key
role
mainli
viru
entri
case
also
viru
bud
viroporin
come
action
virus
need
exit
cell
earli
membran
permeabil
alway
carri
virion
compon
case
envelop
virus
earli
event
execut
structur
glycoprotein
coupl
fusion
process
understand
fusion
molecular
level
also
requir
explan
phenomenon
earli
membran
permeabil
advanc
idea
viral
glycoprotein
involv
membran
fusion
particip
dissip
chemiosmot
gradient
thu
provid
energi
push
nucleocapsid
neighbor
macromolecul
cell
interior
carrasco
irurzun
et
al
fusion
glycoprotein
simpli
serv
bridg
cellular
viral
membran
instead
design
open
pore
membran
poreopen
activ
may
necessari
lower
membran
potenti
dissip
ionic
gradient
sever
chapter
book
devot
detail
descript
structur
function
glycoprotein
focu
attent
viral
glycoprotein
permeabil
membran
individu
express
cell
membran
activ
protein
may
exhibit
activ
later
viru
life
cycl
rotaviru
infect
provok
number
alter
cellular
membran
infect
amongst
alter
increas
concentr
cytoplasm
calcium
sever
rotaviru
protein
exhibit
membranedestabil
activ
enterotoxin
induc
alter
membran
permeabl
tian
et
al
individu
express
nonstructur
glycoprotein
abil
increas
concentr
cytoplasm
calcium
increas
may
mediat
activ
phospholipas
c
activ
dong
et
al
rotaviru
particl
induc
coentri
protein
toxin
cell
cuadra
et
al
least
two
structur
compon
possess
abil
permeabil
cell
includ
protein
glycoprotein
charpilienn
et
al
irurzun
et
al
infect
lymphocyt
human
cell
enhanc
membran
permeabl
ion
sever
compound
voss
et
al
gatti
et
al
least
three
differ
hivencod
protein
respons
alter
vpu
protein
retrovir
proteas
fusion
glycoprotein
apart
fusion
peptid
two
region
exhibit
membran
permeabl
one
locat
carboxi
terminu
arroyo
et
al
comardel
et
al
anoth
correspond
membranespan
domain
arroyo
et
al
cterminu
includ
two
residu
may
form
cation
amphipath
design
lentiviru
lytic
peptid
synthet
peptid
form
pore
planar
phospholipid
bilay
late
earli
figur
particip
pore
format
viral
glycoprotein
viroporin
membran
permeabl
earli
membran
permeabil
coupl
fusion
activ
correspond
viral
glycoprotein
fusion
glycoprotein
may
creat
two
pore
one
locat
target
cell
membran
form
tm
domain
late
membran
permeabil
may
carri
viroporin
tm
domain
viral
glycoprotein
chernomordik
et
al
permeabil
virion
deoxyribonucleosid
triphosph
zhang
et
al
induc
alter
ion
permeabl
xenopu
oocyt
comardel
et
al
induc
express
hepat
c
viru
glycoprotein
increas
membran
permeabl
bacteri
cell
abil
modifi
membran
permeabl
map
carboxi
terminu
protein
ciccaglion
et
al
ciccaglion
et
al
similar
permeabil
found
escherichia
coli
cell
synthes
semliki
forest
viru
glycoprotein
exposur
low
ph
nyfel
et
al
final
overexpress
vaccinia
viru
glycoprotein
produc
chang
morpholog
permeabl
adhes
mammalian
cell
potenti
capac
protein
form
pore
plasma
membran
promot
entri
calcium
ion
pi
releas
lactic
dehydrogenas
cultur
medium
sanderson
et
al
differ
approach
envisag
design
compound
interfer
viru
replic
base
modif
membran
permeabl
one
approach
make
use
inhibitor
cellular
viral
function
permeat
easili
intact
anim
cell
notabl
agent
select
enter
virusinfect
cell
carrasco
benedetto
et
al
inhibitor
use
thu
far
interfer
protein
synthesi
although
compound
affect
function
could
also
employ
entri
agent
lead
inhibit
translat
specif
virusinfect
cell
lead
profound
inhibit
viru
growth
contrera
et
al
carrasco
gatti
et
al
although
approach
discrimin
well
uninfect
virusinfect
cell
cultur
high
toxic
agent
thu
far
assay
hamper
use
whole
anim
perhap
futur
search
less
toxic
compound
would
make
approach
amen
applic
therapi
fact
plant
toxin
coenter
viru
particl
describ
antivir
agent
lee
et
al
even
compound
hygromycin
b
use
veterinari
field
antibacteri
agent
could
also
use
antivir
compound
rotaviru
infect
liprandi
et
al
paradigm
inhibitor
viral
ion
channel
amantadin
hay
figur
compound
use
antiinfluenza
agent
human
de
clercq
target
amantadin
influenzaencod
protein
residu
determin
amantadin
sensit
ion
channel
drawback
amantadin
high
dose
necessari
affect
influenza
search
effect
compound
may
provid
efficaci
treatment
ill
compound
interfer
function
viroporin
also
describ
case
amilorid
deriv
block
vpu
activ
ewart
et
al
manner
product
infecti
reduc
presenc
agent
recent
long
alkylchain
iminosugar
deriv
found
interfer
function
hepat
c
viru
protein
ion
channel
griffin
et
al
pavlov
et
al
compound
exhibit
antivir
activ
bovin
viral
diarrhea
viru
close
relat
hepat
c
viru
durantel
et
al
much
effort
concentr
recent
develop
antivir
agent
inhibit
fusion
step
hiv
bind
hiv
receptor
follow
interact
viral
glycoprotein
coreceptor
molecul
initi
interact
conform
ectodomain
tm
glycoprotein
profoundli
modifi
exposur
fusion
peptid
amino
terminu
trigger
insert
target
cellular
membran
lead
fusion
viral
cellular
plasma
membran
step
use
target
antihiv
therapi
cooley
lewin
regard
fusion
step
varieti
peptid
mimet
inhibitor
develop
pioneer
work
peptid
demonstr
compound
potent
inhibitor
membran
fusion
exhibit
antivir
activ
hivinfect
patient
detail
mechan
action
molecular
level
known
peptid
homolog
amino
acid
within
ctermin
heptad
repeat
region
competit
bind
interfer
format
six
helix
bundl
complex
necessari
membran
fusion
present
great
number
peptid
interfer
bind
membran
fusion
test
antihiv
activ
clinic
efficaci
regard
one
second
gener
peptid
mimet
inhibitor
consist
amino
acid
pro
solubl
receptor
bind
neutral
viru
bind
occur
schc
oximepiperidin
compound
coreceptor
antagonist
small
molecul
act
inhibitor
nonpeptid
low
molecular
weight
bicyclam
compound
prevent
interact
block
signal
transduct
futur
research
field
provid
us
addit
antivir
compound
add
antihiv
armori
